TCL Archive Progression-free survival as a primary endpoint for drug approval requires prospective planning, FDA’s Pazdur says. May 7, 2004
TCL Archive In Brief: Hatch To Speak At AACI Dinner; NIH Plans 1987 Centennial; Cox To Head Columbia Radiotherapy May 24, 1985
